EMEA-002267-PIP02-19

Key facts

Active substance
gefapixant (citrate)
Therapeutic area
Pneumology-allergology
Decision number
P/0380/2019
PIP number
EMEA-002267-PIP02-19
Pharmaceutical form(s)
Film-coated tablet
Condition(s) / indication(s)
Treatment of unexplained or chronic refractory cough
Route(s) of administration
Oral use
Contact for public enquiries
Merck Sharp & Dohme (Europe) Inc.

E-mail: pip.information@merck.com
Tel.: ++33 180464738

Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

How useful was this page?

Add your rating